Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Broadcom Serves Up a Trend-Following Entry for Investors: https://www.marketbeat.com/logos/articles/med_20240906094800_chart-avgo-962024.png
Broadcom Serves Up a Trend-Following Entry for Investors

Investors who missed out on Broadcom’s (NASDAQ: AVGO) first post-stock-split dip have another opportunity. Down 10% following its Q3 results and guidance, it is a knee-jerk move driven by market

Broadcom Serves Up a Trend-Following Entry for Investors: https://www.marketbeat.com/logos/articles/med_20240906094800_chart-avgo-962024.png
Broadcom Serves Up a Trend-Following Entry for Investors

Investors who missed out on Broadcom’s (NASDAQ: AVGO) first post-stock-split dip have another opportunity. Down 10% following its Q3 results and guidance, it is a knee-jerk move driven by market

Intel Eyes Foundry Sale: Is This the Solution to Its Stock Woes?: https://www.marketbeat.com/logos/articles/med_20240905200121_intel-eyes-foundry-sale-is-this-the-solution-to-it.jpg
Intel Eyes Foundry Sale: Is This the Solution to Its Stock Woes?

Intel (NASDAQ: INTC) has had a terrible 2024, to say the least. The company’s shares are down 61% year-to-date, driven largely by a massive earnings miss in August. Criticism has been laid on

Intel Eyes Foundry Sale: Is This the Solution to Its Stock Woes?: https://www.marketbeat.com/logos/articles/med_20240905200121_intel-eyes-foundry-sale-is-this-the-solution-to-it.jpg
Intel Eyes Foundry Sale: Is This the Solution to Its Stock Woes?

Intel (NASDAQ: INTC) has had a terrible 2024, to say the least. The company’s shares are down 61% year-to-date, driven largely by a massive earnings miss in August. Criticism has been laid on

Intel Eyes Foundry Sale: Is This the Solution to Its Stock Woes?: https://www.marketbeat.com/logos/articles/med_20240905200121_intel-eyes-foundry-sale-is-this-the-solution-to-it.jpg
Intel Eyes Foundry Sale: Is This the Solution to Its Stock Woes?

Intel (NASDAQ: INTC) has had a terrible 2024, to say the least. The company’s shares are down 61% year-to-date, driven largely by a massive earnings miss in August. Criticism has been laid on

Intel Eyes Foundry Sale: Is This the Solution to Its Stock Woes?: https://www.marketbeat.com/logos/articles/med_20240905200121_intel-eyes-foundry-sale-is-this-the-solution-to-it.jpg
Intel Eyes Foundry Sale: Is This the Solution to Its Stock Woes?

Intel (NASDAQ: INTC) has had a terrible 2024, to say the least. The company’s shares are down 61% year-to-date, driven largely by a massive earnings miss in August. Criticism has been laid on

Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors: https://www.marketbeat.com/logos/articles/med_20240905092744_chart-hpe-952024.png
Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors

Hewlett Packard Enterprises (NYSE: HPE) is an attractive, high-yield play for blue-chip investors seeking exposure to AI because of its position in the enterprise industry, cash flow, and

The Fundamental Issue With NVIDIA Might Be Its Fundamentals: https://www.marketbeat.com/logos/articles/med_20240905202705_the-fundamental-issue-with-nvidia-might-be-its-fun.png
The Fundamental Issue With NVIDIA Might Be Its Fundamentals

Is NVIDIA Corp. (NASDAQ: NVDA) a proxy for the broader market? It sure looks like it. In late August, the world’s leading microchip manufacturer delivered a strong earnings report. However

The Fundamental Issue With NVIDIA Might Be Its Fundamentals: https://www.marketbeat.com/logos/articles/med_20240905202705_the-fundamental-issue-with-nvidia-might-be-its-fun.png
The Fundamental Issue With NVIDIA Might Be Its Fundamentals

Is NVIDIA Corp. (NASDAQ: NVDA) a proxy for the broader market? It sure looks like it. In late August, the world’s leading microchip manufacturer delivered a strong earnings report. However

The Fundamental Issue With NVIDIA Might Be Its Fundamentals: https://www.marketbeat.com/logos/articles/med_20240905202705_the-fundamental-issue-with-nvidia-might-be-its-fun.png
The Fundamental Issue With NVIDIA Might Be Its Fundamentals

Is NVIDIA Corp. (NASDAQ: NVDA) a proxy for the broader market? It sure looks like it. In late August, the world’s leading microchip manufacturer delivered a strong earnings report. However

Why NVIDIA Is More of a Screaming Buy Than Ever: https://www.marketbeat.com/logos/articles/med_20240905084552_why-nvidia-is-more-of-a-screaming-buy-than-ever.jpg
Why NVIDIA Is More of a Screaming Buy Than Ever

Few investors at the start of the year would have expected NVIDIA Corporation (NASDAQ: NVDA) to be “trading in bear territory” by the end of the summer. But that’s exactly what Goldman Sachs

Why NVIDIA Is More of a Screaming Buy Than Ever: https://www.marketbeat.com/logos/articles/med_20240905084552_why-nvidia-is-more-of-a-screaming-buy-than-ever.jpg
Why NVIDIA Is More of a Screaming Buy Than Ever

Few investors at the start of the year would have expected NVIDIA Corporation (NASDAQ: NVDA) to be “trading in bear territory” by the end of the summer. But that’s exactly what Goldman Sachs

Why NVIDIA Is More of a Screaming Buy Than Ever: https://www.marketbeat.com/logos/articles/med_20240905084552_why-nvidia-is-more-of-a-screaming-buy-than-ever.jpg
Why NVIDIA Is More of a Screaming Buy Than Ever

Few investors at the start of the year would have expected NVIDIA Corporation (NASDAQ: NVDA) to be “trading in bear territory” by the end of the summer. But that’s exactly what Goldman Sachs

Don't Miss These 3 Stocks Set to Defy Expectations in September: https://www.marketbeat.com/logos/articles/med_20240905082450_dont-miss-these-3-stocks-set-to-defy-expectations.jpg
Don't Miss These 3 Stocks Set to Defy Expectations in September

September is often volatile for the stock market, with opportunities for investors to capitalize on market shifts. While economic uncertainty lingers, fueled by factors like inflation, rising

Don't Miss These 3 Stocks Set to Defy Expectations in September: https://www.marketbeat.com/logos/articles/med_20240905082450_dont-miss-these-3-stocks-set-to-defy-expectations.jpg
Don't Miss These 3 Stocks Set to Defy Expectations in September

September is often volatile for the stock market, with opportunities for investors to capitalize on market shifts. While economic uncertainty lingers, fueled by factors like inflation, rising

Don't Miss These 3 Stocks Set to Defy Expectations in September: https://www.marketbeat.com/logos/articles/med_20240905082450_dont-miss-these-3-stocks-set-to-defy-expectations.jpg
Don't Miss These 3 Stocks Set to Defy Expectations in September

September is often volatile for the stock market, with opportunities for investors to capitalize on market shifts. While economic uncertainty lingers, fueled by factors like inflation, rising

Introduction to Fibonacci Retracement Levels: https://www.marketbeat.com/logos/articles/med_20240904080908_fibchart-nvda.jpg
Introduction to Fibonacci Retracement Levels

Two emotions rule financial markets: fear and greed. Fear can arise when a stock position is losing money, and greed rears its head when a stock position is making money. The fear of missing out

Introduction to Fibonacci Retracement Levels: https://www.marketbeat.com/logos/articles/med_20240904080908_fibchart-nvda.jpg
Introduction to Fibonacci Retracement Levels

Two emotions rule financial markets: fear and greed. Fear can arise when a stock position is losing money, and greed rears its head when a stock position is making money. The fear of missing out

Introduction to Fibonacci Retracement Levels: https://www.marketbeat.com/logos/articles/med_20240904080908_fibchart-nvda.jpg
Introduction to Fibonacci Retracement Levels

Two emotions rule financial markets: fear and greed. Fear can arise when a stock position is losing money, and greed rears its head when a stock position is making money. The fear of missing out

Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out: https://www.marketbeat.com/logos/articles/med_20240830090836_veevas-stock-jumps-on-stellar-q2-resultsdont-miss.jpg
Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out

Shares of cloud-based software provider Veeva Systems Inc. (NYSE: VEEV) have been on a wild ride in the last year, surging by more than 40% from last November through March 2024 before giving up

Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out: https://www.marketbeat.com/logos/articles/med_20240830090836_veevas-stock-jumps-on-stellar-q2-resultsdont-miss.jpg
Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out

Shares of cloud-based software provider Veeva Systems Inc. (NYSE: VEEV) have been on a wild ride in the last year, surging by more than 40% from last November through March 2024 before giving up

Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out: https://www.marketbeat.com/logos/articles/med_20240830090836_veevas-stock-jumps-on-stellar-q2-resultsdont-miss.jpg
Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out

Shares of cloud-based software provider Veeva Systems Inc. (NYSE: VEEV) have been on a wild ride in the last year, surging by more than 40% from last November through March 2024 before giving up

Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results: https://www.marketbeat.com/logos/articles/med_20240829092536_affirm-shows-buy-now-pay-later-is-here-to-stay-in.jpg
Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results

Affirm (NASDAQ: AFRM) has seen wild fluctuations in its stock price over the past three years. Shares peaked at nearly $169 in November 2021 but are down 80% from that level today. However

Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results: https://www.marketbeat.com/logos/articles/med_20240829092536_affirm-shows-buy-now-pay-later-is-here-to-stay-in.jpg
Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results

Affirm (NASDAQ: AFRM) has seen wild fluctuations in its stock price over the past three years. Shares peaked at nearly $169 in November 2021 but are down 80% from that level today. However

Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results: https://www.marketbeat.com/logos/articles/med_20240829092536_affirm-shows-buy-now-pay-later-is-here-to-stay-in.jpg
Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results

Affirm (NASDAQ: AFRM) has seen wild fluctuations in its stock price over the past three years. Shares peaked at nearly $169 in November 2021 but are down 80% from that level today. However